Hematological Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Leukemia Remission Seen with Immune Therapy

An experimental immune-system therapy can often lead to complete remission in advanced acute lymphoblastic leukemia (ALL) patients who have run out of other options.

Blinatumomab BLA Being Reviewed

Amgen announced that the Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for blinatumomab

Fast Tracked Sickle Cell Disease Agent

NKT Therapeutics announced that the Food and Drug Administration (FDA) has granted Fast Track designation to NKTT120 for the treatment of sickle cell disease.

Transfusion Threshold and Sepsis Outcomes

For patients in the intensive care unit (ICU) with septic shock, outcomes are similar for those who receive blood transfusion at a higher or lower hemoglobin threshold.

Blood Type and Cognitive Impairment Risk

Blood group AB and higher factor VIII are associated with increased incidence of cognitive impairment.

New Velcade Indication

Millennium: The Takeda Oncology Company announced that the Food and Drug Administration (FDA) has approved Velcade (bortezomib) for the treatment of mantle cell lymphoma (MCL) in previously untreated patients.version of Eisai's Dacogen.

Bacon as Nosebleed Treatment?

Physicians at the Detroit Medical Center have been awarded a unique prize for an unconventional treatment – using bacon to stop an uncontrollable nosebleed in a 4-year-old with Glanzmann thrombasthenia.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Vertebroplasty is effective for managing myelomatous VCFsExternal web site

Nurse awareness of this treatment option and the patient selection criteria may be a significant ...

CE 0.60 Credits

Lung cancer: Guidelines, new drugs improve outcomesExternal web site

Advances in screening and FDA approval of two new targeted therapies have significantly impacted outcomes ...

CE 0.90 Credits

Sign Up for Free e-newsletters